# Cipla Limited (CIPLA)

> CIPLA closed at ₹1,378.90 on 30 Oct 2026, trailing P/E 38.5, market cap ₹1,11,394 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Cipla Limited (NSE: CIPLA) closed at ₹1,378.90 on 30 Oct 2026, -12.6% over one year, against a 52-week range of ₹1,165.70 – ₹1,673.00.

In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹7,404 cr and net profit of ₹878 cr, a 11.9% net margin; revenue fell 2.4% and profit fell 36.5% year on year.

On four consecutive filed quarters its trailing P/E is 38.5; since 13 May 2025 its own P/E has ranged from 21.0 to 38.4 (median 23.6), and today's reading is higher than 100% of those 363 trading days.

From the balance sheet dated 30 Sept 2026: return on equity 9.9%, ROCE 13.1%, debt-to-equity 0.01, Piotroski F-score 4 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 40% of 63 sector peers; PBT margin higher than 38% of 63 sector peers; ROE higher than 25% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹1,378.90 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -1.4% / +6.5% / -12.6% |
| 52-week low – high | ₹1,165.70 – ₹1,673.00 |
| Market capitalisation | ₹1,11,394 cr |
| Trailing P/E | 38.5 |
| Price / book | 3.15 |
| EV / EBITDA | 21.0 |
| Earnings yield | 2.6% |
| TTM EPS | ₹35.86 |
| TTM net profit | ₹2,897 cr |
| Quarter revenue | ₹7,404 cr |
| Quarter net profit | ₹878 cr |
| Net margin | 11.9% |
| Revenue growth (YoY) | -2.4% |
| Profit growth (YoY) | -36.5% |
| Return on equity | 9.9% |
| ROCE | 13.1% |
| Debt / equity | 0.01 |
| Current ratio | 3.59 |
| Free cash flow | ₹302 cr |
| Piotroski F-score | 4 / 9 |
| Average daily turnover (50 days) | ₹113.6 cr |

## Questions

### What is the P/E ratio of Cipla Limited?

Cipla Limited's trailing P/E is 38.5, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 13 May 2025 its P/E has ranged 21.0–38.4.

### What were Cipla Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Cipla Limited reported revenue of ₹7,404 cr and net profit of ₹878 cr (consolidated), filed with the exchange on 27 Oct 2026.

### What is Cipla Limited's ROE?

Return on equity is 9.9% based on the balance sheet dated 30 Sept 2026.

### Does Cipla Limited have debt?

Debt-to-equity is 0.01 on the balance sheet dated 30 Sept 2026.

### What is CIPLA's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, CIPLA traded between ₹1,165.70 and ₹1,673.00.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/CIPLA

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._